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Environmental samplesPurpose: PCR assay is a highly sensitive, specific and reliable diagnostic tool for the identi-
fication of pathogens in many infectious diseases. Genome sequencing Mycobacterium lep-
rae revealed several gene targets that could be used for the detection of DNA from clinical
and environmental samples. The PCR sensitivity of particular gene targets for specific clin-
ical and environmental isolates has not yet been established. The present study was con-
ducted to compare the sensitivity of RLEP, rpoT, Sod A and 16S rRNA gene targets in the
detection of M. leprae in slit skin smear (SSS), blood, soil samples of leprosy patients and
their surroundings.
Method: Leprosy patients were classified into Paucibacillary (PB) and Multibacillary (MB)
types. Ziehl–Neelsen (ZN) staining method for all the SSS samples and Bacteriological Index
(BI) was calculated for all patients. Standard laboratory protocol was used for DNA extrac-
tion from SSS, blood and soil samples. PCR technique was performed for the detection ofM.
leprae DNA from all the above-mentioned samples.
Results: RLEP gene target was able to detect the presence of M. leprae in 83% of SSS, 100% of
blood samples and in 36% of soil samples and was noted to be the best out of all other gene
targets (rpoT, Sod A and 16S rRNA). It was noted that the RLEP gene target was able to detect
the highest number (53%) of BI-negative leprosy patients amongst all the gene targets used
in this study.
Conclusion: Amongst all the gene targets used in this study, PCR positivity using RLEP gene
target was the highest in all the clinical and environmental samples. Further, the RLEP gene
target was able to detect 53% of blood samples as positive in BI-negative leprosy cases indi-
cating its future standardization and use for diagnostic purposes.
 2015 Asian African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 5 4 –5 9 55mental samples (soil) which were obtained from patientsTable 1 – SSS samples of PB and MB leprosy patients.
BI grading Number of
PB cases
Number of
MB cases
Total number
of cases
0 30 – 30
1+ – 6 6
2+ – 6 6
3+ – 6 6
4+ – 6 6
5+ – 6 6
Total 30 30 60
BI = Bacteriological Index; PB = Paucibacillary; MB = Multibacillary.Introduction
Leprosy is a chronic infectious disease of humans caused by
Mycobacterium leprae and was discovered by G.A. Hansen in
1873.M. leprae is a non-cultivablemycobacteria, and diagnosis
of the disease is based on its clinical, histopathological charac-
teristics and finding the bacteria in skin scrapings and in biop-
sies taken from the patients. Due to its long incubation period
and because very early lesions often do not satisfy the cardinal
signs of leprosy, it becomes difficult to diagnose the disease in
the early stages. Therefore, there is anurgent need to develop a
tool for diagnosing the disease early so that the patient can be
covered with chemotherapy under the control program. The
diagnosis of leprosy is routinely based on clinical symptoms
and finding acid-fast bacilli (AFB) in smears of skin scrapings.
AFB staining technique requires the presence of at least 104
organisms per gram of tissue for its reliable detection under
themicroscope [1] and thus the organismshaveavery low sen-
sitivity of detection, especially in patients with intermediate
lesions and at the Tuberculoid (TT)/Borderline Tuberculoid
(BT) endof thedisease spectrumwhereAFBsare rare or absent.
Several attempts have been made in the past to establish a
test for the diagnosis of early leprosy; however, none of the
tests were successful in diagnosing more than 60% of early
cases of leprosy [2–5] and, therefore, til today, there is no lab-
oratory-based specific and sensitive assay for the detection of
early leprosy.
Modern molecular methods like amplification by polymer-
ase chain reaction (PCR) are more specific and sensitive for
detecting bacillary DNA in clinical samples [6]. During the last
30 years, PCR methods have been developed to amplify differ-
ent gene targets of M. leprae, but it is not known which target
is most suitable for the diagnosis of leprosy. RLEP was found
to be very sensitive and specific for M. leprae and detects
10 fg of purified M. leprae DNA [7,8]. 16S rRNA is a gene con-
served in bacteria which codes for the 16S part of the ribo-
some [9,10]. It has been used for RT-PCR targeting 16S rRNA
for identification of viable bacilli from patients. Martinez
et al. reported that with regard to 16S rRNA and RLEP, RT-
PCR acts as a better target compared with superoxide dismutase
(Sod A) and RLEP RT-PCR for viability testing of M. leprae [11].
Enormous numbers of leprosy bacilli are expelled into the
environment from the nasal discharges of lepromatous
patients [12]. There is also evidence to support the excretion
of bacilli from skin lesions [13,14]. A single mouth-wash of
an LL patient may discharge 1.6 millionM. leprae [15]. The risk
of transmission of leprosy in the community, therefore, is
subject to the availability of leprosy cases and other related
environmental factors. There are evidences to support that
M. leprae is able to survive for many days in the environment.
Soil is known to be a medium which can preserve a variety of
microorganisms [16]. Although PCR has already been applied
for the detection of M. leprae for many years, it has been used
mainly in samples from biopsies and SSS of leprosy and sus-
pected cases and not in environmental samples.
The aim of the present study is to evaluate the usefulness
of the PCR method on different clinical and environmental
samples using different gene targets, such as RLEP, rpoT, sod
A and 16S rRNA genes, and compare their efficiency in PCRpositivity in clinical samples (blood and SSS) and environ-
and from their surroundings.
Materials and methods
Ethical approval
Informed consent was obtained from all the patients, and the
study was approved by the Ethical Committee of The Leprosy
Mission Trust India.
Recruitment of patients
Thirty newly diagnosed AFB negative PB and 30 MB leprosy
cases as per standard criteria of the World Health Organisa-
tion (WHO) were enrolled from the Outpatient Department
of the TLM Hospital Shahdara, Delhi and Purulia, West
Bengal. Grading of the bacterial load was determined by ZN
staining of SSS. Fifty soil samples were collected in sterile
plastic containers following a procedure described earlier
[17] from residing areas and/or around the houses of leprosy
patients staying in different villages of different blocks of
the Purulia district of West Bengal (Table 1).
Sampling area
Different blocks of Purulia, West Bengal and Shahdara of
Delhi were selected for sampling.
Slit skin smear sample collection
SSSsampleswerecollectedafter taking fourhorizontal scrapes
of tissue from an incision (5 mm long and 2 mm deep) made
with the help of a sterile surgical scalpel blade (No. 15) on the
left and right earlobes and skin lesions without any contami-
nation with blood along the skin-slit part. The tissue material
thus obtained on the blade by scraping was placed in 700 ll of
70% ethanol and mixed well in a micro-centrifuge tube. Later
the SSS suspensions were kept at 4 C for further use.
Collection of blood samples
Blood samples (2 ml each) were withdrawn from patients
by antecubital venipuncture and collected in an EDTA vial;
Table 2 – Blood samples of PB and MB leprosy patients.
BI grading Number of
PB cases
Number of
MB cases
Total number
of cases
0 30 – 30
1+ – 6 6
2+ – 6 6
3+ – 6 6
4+ – 6 6
5+ – 6 6
Total 30 30 60
BI = Bacteriological Index; PB = Paucibacillary; MB = Multibacillary.
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using standard protocol as mentioned below (see Table. 2).
Collection of soil sample
50 soil samples were collected in clean plastic containers (10 g
each) with the help of a hand trowel and labelled with a site
code and the village name. Specific locations for the collection
of soil samples were the bathing place, common sitting place,
near the entrance of the house, areas around the house used
for washing and a place near the bore well. Collected samples
were transported to the laboratory at room temperature
(within 2 days) and stored at 4–8 C until further processing.
Extraction of DNA from slit sample
M. leprae DNAwas isolated from SSS samples by Proteinase K
lysis method [18]. Briefly, SSS sampleswere collected and kept
in 70% ethanol. Then all the tubes were again centrifuged at
10,000· rpm for 10 min, and the supernatant was discarded.
The pellet was dried in an incubator at 37 C for 2 h; 200 ll
of lysis buffer was added to the dried pellet. The pellets with
lysis buffer were kept at 60 C for overnight or 16 h in a shak-
ing water bath for lysis. The lysis reaction was terminated by
inactivating Proteinase K by incubation at 97 C for 15 min.
Lysates were stored at 20 C until further use.
Extraction of DNA from blood sample
DNA was extracted and purified using a Master Pure DNA
extraction Kit (Epicentre Technologies, USA) according to
the manufacturer’s instructions.
Extraction of DNA from soil sample by using kit
DNAwas extracted and purified using a Power Soil DNA Isola-
tion Kit (MO BIO-laboratories, USA) according to the manufac-
turer’s instructions.
Polymerase chain reaction
DNA PCR amplification was carried out by using different
gene targets of M. leprae. A total of 25 ll of reaction volume
that contained 2 ll of template DNA, primers at a final con-
centration of 0.5 lM (forward and reverse) and 1· Genei Mix
(Merck India). M. leprae-specific RLEP primers sequences PS15 0-TGC ATG TCA TGG CCT TGA GG-3 0 and PS 2 5 0-CAC CGA
TAC CAG CGG CAG AA-3 0 were used [7]. Amplification con-
sisted of first stage of single cycle of denaturation at 95 C
for 5 min followed by second stage of 35–45 cycles of 30 s at
94 C, 30 s at 58 C and 1 min at 72 C, and final stage of single
cycle of 10 min at 72 C. The M. leprae specific 16S rRNA prim-
ers (P2: 5 0-TCG AAC GGA AAG GTC TCTAAA AAATC-3 0 and P3:
5 0-CCT GCA CCG CAA AAA GCT TTC C-3 0) described earlier
were used [19]. PCR reaction without DNA was used as the
negative control (reagent control). Purified M. leprae DNA
was used as the positive control. The amplification was car-
ried out in a thermal cycler (Corbett Research, Australia)
under the following conditions of 95 C for 5 min for initial
denaturation followed by 37 cycles, each cycle consisting of
denaturation at 95 C for 30 s, primer annealing at 60 C for
2 min and extension at 72 C for 3 min followed by a final
extension at 72 C for 10 min. rpoT PCR amplification was car-
ried out by using M. leprae DNA as per the protocol described
earlier [20]. rpoT Primer A (VIC-5 0-ATG CCGAACCGGACCTC-
GACGTTGA-3 0) and B (5 0-TCGTCTTCGAGGTCGTCGAGA-3 0)
(Gene Bank Accession No. AB019194) which were used for
amplification span the 91 bp (containing 3 repeats) or 97 bp
(containing 4 repeats) fragments of the rpoT gene target. The
amplification was carried out in a thermal cycler (Corbett
Research, Australia) under the conditions of 95 C for 5 min
for initial denaturation followed by 40 cycles, each cycle con-
sisting of denaturation at 95 C for 30 s, annealing at 60 C for
2 min and extension at 72 C for 3 min followed by a final
extension at 72 C for 10 min. The M. leprae specific Sod A
primers (Sod A-F GGCCAGGTTCTTCTCGTTCA and Sod A-R
CGCCGCATATGTCAAAGGTG) described earlier were used
[21]. The amplification was carried out in a thermal cycler
(Corbett Research, Australia) under the following conditions
of 95 C for 5 min for initial denaturation followed by 37
cycles, each cycle consisting of denaturation at 95 C for
30 s, primer annealing at 60 C for 90 s and extension at
72 C for 60 s followed by a final extension at 72 C for
10 min. PCR product containing an amplified fragment of
the target region was electrophoresed in agarose (Sigma) gel
using Tris–Borate–EDTA buffer at 100 V constant voltage.Results
It is noted from Table 3 that RLEP showed the highest (83%)
positivity for M. leprae in SSS compared with rpoT (70%), Sod
A (57%) and 16S rRNA (60%) gene targets, respectively (Figs. 1
and 2). When PCR positivity forM. leprae in blood samples was
compared, it was observed that all the BI positive cases were
RLEP positive (100%), while the positivity for other targets
were 80%, 90%, 43% for rpoT, Sod A and 16S rRNA, respectively
(Table 4).
It was interesting to note that RLEP showed the highest
positivity of 30% of SSS and 53% of blood samples of BI nega-
tive PB cases amongst all the gene targets (Table 5).
All 50 soil samples were screened by using the aforemen-
tionedM. leprae gene targets. It was observed that PCR positiv-
ity of M. leprae DNA from soil samples was the highest using
the RLEP region (36%) as compared with 16S rRNA gene
(30%), Sod A (0%), and rpoT (0%) (Fig. 3).
Table 3 – PCR positivity from SSS samples.
BI Total number RLEP PCR positivity rpoT PCR positivity Sod A PCR positivity 16S rRNA PCR positivity
1+ 6 4 (67%) 4 (67%) 2 (33%) 2 (33%)
2+ 6 4 (67%) 4 (67%) 3 (50%) 2 (33%)
3+ 6 5 (83%) 4 (67%) 3 (50%) 4 (67%)
4+ 6 6 (100%) 4 (67%) 4 (67%) 3 (50%)
5+ 6 6 (100%) 5 (83%) 5 (83%) 5 (83%)
Total 30 25 (83%) 21 (70%) 17 (57%) 18 (60%)
100bp Ladder
129 bp RLEP
PCR
171bp 
16S rRNA
PCR
1                           2       3       4       5        6       7       8       9       10     11     12   
PCR  products were electrophoresis on 2% Agarose gel. Samples were Lane 1:  100bp 
ladder, Lane 2: Negative control; Lane 3: positive control, Lane 4-7: RLEP PCR 
product using SSS samples, Lane 8-12: 16S rRNA PCR product using SSS samples.
Fig. 1 – Shows PCR amplification of representative M. leprae gene targets of RLEP, 16S rRNA gene targets from SSS samples.
1      2       3      4       5       6      7      8       9              10    11     12   13   14     15    16    17  
50bp 
Ladder
91 bp rpoT 
region
103bp SodA
PCR
PCR products were electrophoresis on 3% Agarose gel. Samples were Lane 1: 50bp ladder,
Lane 2: Negative control, Lane 3: positive control, Lane 4-9: SSS samples for rpoT region,
Lane 10-15: SSS samples for Sod A region, Lane 16: negative control, Lane 14: positive control.
Fig. 2 – Shows PCR amplification of representative M. leprae gene targets of rpoT, Sod A gene targets from SSS samples.
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Although leprosy is one of the oldest infectious diseases that
has inflicted man from biblical times, many questions on
modes of entry, incubation period of the disease and early
manifestation of the disease are still not known. Over the last
few years, several articles have been published on PCR-med-
iated amplification of M. leprae DNA, and these data suggest
that PCR could be a useful tool for the detection of infection
with this pathogen. Identification of M. leprae is difficult from
a biological sample due to its inability of the leprosy bacillus
to grow in vitro. The diagnosis of leprosy is based on micro-scopic detection of AFB in tissue smears, in combination with
histopathological and clinical evaluation. Because acid-fast
staining requires at least the presence of 104 organisms per
gram of tissue for reliable detection [22], sensitivity of detec-
tion is low, particularly for the majority of PB patients
wherein AFB are rare or absent.
In the past 30 years, definitive identification of M. leprae
has been possible through the development of methods for
the amplification and identification of M. leprae DNA in clini-
cal and environmental samples using PCR. The techniques
have been applied not only to skin biopsy samples, but also
to several different types of specimens, such as skin smears,
Table 4 – PCR positivity from blood samples by using different gene targets of M. leprae.
BI Total Number RLEP PCR positivity rpoT PCR positivity Sod A PCR positivity 16S rRNA PCR positivity
1+ 6 4 (67%) 4 (67%) 2 (33%) 2 (33%)
2+ 6 4 (67%) 4 (67%) 3 (50%) 2 (33%)
3+ 6 5 (83%) 4 (67%) 3 (50%) 4 (67%)
4+ 6 6 (100%) 4 (67%) 4 (67%) 3 (50%)
5+ 6 6 (100%) 5 (83%) 5 (83%) 5 (83%)
Total 30 25 (83%) 21 (70%) 17 (57%) 18 (60%)
Table 5 – Comparison of BI negative SSS and blood samples with PCR assay by using different gene targets.
Samples BI Total number RLEP PCR positivity 16S rRNA gene positivity SodA gene positivity rpoT positivity
SSS samples Neg 30 9 (30%) 5 (17%) 2 (7%) 3 (10%)
Blood samples Neg 30 16 (53%) 3 (10%) 6 (20%) 0 (00%)
0%
5%
10%
15%
20%
25%
30%
35%
40%
RLEP gene target 16S rRNA gene 
target
Sod A gene target rpoT gene target
36%
30%
0% 0%
Fig. 3 – PCR positivity of M. leprae DNA from soil samples by using different gene targets.
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lesions [23–30]. Different sequences were used as targets for
PCR, such as genes encoding antigen 85 [26], 16S rDNA [21],
RLEP [8] and sod A [21]. The M. leprae chromosome contains
a family of dispersed repeats (RLEP) of variable structure and
unknown function [31], and it was noted that the presence
of the sequence of RLEP in M. leprae chromosome was
repeated 28 times [21]. RLEP RT-PCR acts as a better target
compared with Sod A for viability testing of M. leprae. It has
demonstrated that the level of the Sod A gene transcript
was reduced to only 5% compared with 16S rRNA gene, which
was reduced to 38% within 48 h after rifampicin treatment.
However, after a week of treatment, both were essentially at
the background levels. rpoT gene, a homolog of the mycobac-
terial principle sigma factor, has been found recently to be
present in three copies in most strains of M. leprae, including
Tamil Nadu strain (TN), but in four copies in others [20,32].
There are very few studies that focus on the detection of
M. leprae from whole-blood samples. In the present study,
the efficacy of PCR of several M. leprae gene targets in blood
and SSS samples of AFB-negative PB and AFB-positive MBleprosy patients and soil samples collected from the sur-
roundings of patients were investigated. RLEP PCR positivity
from both blood and SSS samples was found to be the highest
(100%, 83%) when compared with other gene targets ofM. lep-
rae. These results suggest that RLEP PCR could be used for the
early detection of leprosy cases and for follow-up of the
patients to assess bacterial load reduction during chemother-
apy. Even though 83% of RLEP PCR positivity was observed
from SSS samples of MB cases, all these cases were found
to be positive in PCR from blood samples. Further, while in
this study RLEP PCR was 100% positive, it was shown to be
53% positive in MB cases of leprosy [24]. In addition, the pres-
ent study could also diagnose 53% of BI negative PB cases.
PCR positivity was highest among all the clinical and envi-
ronmental samples by using the RLEP region of M. leprae. All
these findings for the first time clearly demonstrated that
the RLEP target is the most suitable out of all the other targets
for identifying M. leprae gene either in the clinical samples or
in the environmental samples. Future research may be direc-
ted using RLEP PCR in developing and standardizing an early
diagnostic assay for leprosy.
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